Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy
Barry J. Maron, MD, FACC*,*,
Iacopo Olivotto, MD ,
Pietro Bellone, MD ,
Maria Rosa Conte, MD ,
Franco Cecchi, MD ,
Björn P. Flygenring, MD, FACC*,
Susan A. Casey, RN*,
Thomas E. Gohman, BA*,
Sergio Bongioanni, MD and
Paolo Spirito, MD, FACC||
* Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
Ospedale di Careggi, Florence, Italy
Ospedale Santa Corona, Pietra Ligure, Italy
Ospedale di Rivoli, Turin, Italy
|| Ente Ospedaliero Ospedali Galliera, Genoa, Italy

View larger version (30K):
[in a new window]
|
Figure 1 Profile of stroke and other peripheral vascular events among 900 patients with hypertrophic cardiomyopathy (HCM). AF = atrial fibrillation; CNS = central nervous system.
|
|

View larger version (47K):
[in a new window]
|
Figure 2 Distribution of ages at the time of the initial vascular event in 51 patients with hypertrophic cardiomyopathy (HCM), shown separately for those patients who survived (shaded areas of bars) or died (open areas of bars).
|
|

View larger version (42K):
[in a new window]
|
Figure 3 Comparison of selected clinical features of hypertrophic cardiomyopathy (HCM) in patients with (n = 51) or without (n = 849) stroke and other peripheral vascular events, based on univariate analysis. AF = atrial fibrillation; LA = left atrial.
|
|
|